Press release
Global Vaccine Contract Manufacturing Market Size to grow at a CAGR of 6.9% to reach USD 3,905.96 million by 2032, Evaluates DelveInsight
DelveInsight's "Vaccine Contract Manufacturing Market Insights, Competitive Landscape and Market Forecast-2032" report provides the current and forecast market outlook, forthcoming device innovation, challenges, market drivers and barriers. The report also covers the major emerging products and key Vaccine Contract Manufacturing companies actively working in the market.
To know more about why North America is leading the market growth in the Vaccine Contract Manufacturing market, get a snapshot of the report Vaccine Contract Manufacturing Market Trends
https://www.delveinsight.com/sample-request/vaccine-contract-manufacturing-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Vaccine Contract Manufacturing Overview
Vaccine Contract Manufacturing refers to the outsourcing of vaccine production to specialized third-party organizations known as Contract Manufacturing Organizations (CMOs). These companies provide expertise, advanced facilities, and scalable manufacturing capabilities to support vaccine developers-from early-stage development and clinical trial production to large-scale commercial manufacturing. Services may include formulation, fill-finish, quality testing, packaging, and regulatory support. Vaccine contract manufacturing helps pharmaceutical and biotechnology companies reduce costs, shorten development timelines, and ensure consistent, high-quality production, especially during high-demand periods such as pandemics.
DelveInsight Analysis: The vaccine contract manufacturing market size was valued at USD 2,282.36 million in 2024 and is projected to expand at a CAGR of 6.9% from 2025 to 2032, reaching approximately USD 3,905.96 million by 2032.
Vaccine Contract Manufacturing Market Insights
Geographically, North America is projected to dominate the vaccine contract manufacturing market in 2024, supported by its robust healthcare infrastructure, rigorous regulatory framework, and substantial biopharmaceutical R&D investments. The presence of multiple CMOs equipped with advanced technologies and large-scale manufacturing capabilities, combined with increasing vaccine demand driven by emerging infectious diseases, positions the region as a global leader in this market.
To read more about the latest highlights related to Vaccine Contract Manufacturing, get a snapshot of the key highlights entailed in the Vaccine Contract Manufacturing Insights
https://www.delveinsight.com/report-store/vaccine-contract-manufacturing-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Recent Developments in the Vaccine Contract Manufacturing Market Report
• In August 2024, In August 2024, Africa CDC entered into a strategic agreement with Bavarian Nordic to increase the production of the Mpox vaccine in Africa.
• In July 2024, AstraZeneca announced to invest USD 254 million at its Cambridge facility to expand its vaccine manufacturing capability.
• In May 2024, BioNTech received USD 145 million from CEPI to expand its mRNA vaccine production capacity.
• Thus, owing to such developments in the market, rapid growth will be observed in the Vaccine Contract Manufacturing market during the forecast period
Key Players in the Vaccine Contract Manufacturing Market
Some of the key market players operating in the Vaccine Contract Manufacturing market include- Sanofi, Biovac, Emergent BioSolutions Inc., Lonza Group, Catalent Inc., Boehringer Ingelheim BioXcellence, Wockhardt, WuXi Biologics, Moderna, Inc., Syngene International, Meridian Life Sciences, Eurogentec, IDT Biologika, Serum Institute of India, GlaxoSmithKline (GSK), Soligenix Inc., Curia, Cobra Biologics, BioReliance, Recipharm, Jubilant HollisterStier, and others.
Which MedTech key players in the Vaccine Contract Manufacturing market are set to emerge as the trendsetter explore @ Key Vaccine Contract Manufacturing Companies
https://www.delveinsight.com/sample-request/vaccine-contract-manufacturing-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Analysis on the Vaccine Contract Manufacturing Market Landscape
Additionally, the straightforward production process and lower biosafety requirements of inactivated vaccines enable contract manufacturers to establish facilities more rapidly, helping meet global demand and respond to urgent supply needs. As a result, the increasing adoption of inactivated vaccines is strengthening the vaccine contract manufacturing market, enhancing its contribution to improving vaccine availability and addressing global health challenges.
Overall, these factors are expected to drive growth in this segment, thereby propelling the global vaccine contract manufacturing market.
Scope of the Vaccine Contract Manufacturing Market Report
• Coverage: Global
• Study Period: 2022-2032
• Vaccine Contract Manufacturing Market Segmentation By Vaccine Type: Inactivated Vaccine, Live attenuated Vaccine, RNA Vaccine, Subunit Vaccines, and Toxoid Based Vaccines
• Vaccine Contract Manufacturing Market Segmentation By Expression System: Bacterial Expression Systems, Baculovirus/Insect Expression Systems, Mammalian Expression Systems, and Yeast Expression Systems
• Vaccine Contract Manufacturing Market Segmentation By End-User: Pharmaceutical & Biotechnology Companies, Research Institutes & Academic Laboratories, and Others
• Vaccine Contract Manufacturing Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of the World
• Key Vaccine Contract Manufacturing Companies: Sanofi, Biovac, Emergent BioSolutions Inc., Lonza Group, Catalent Inc., Boehringer Ingelheim BioXcellence, Wockhardt, WuXi Biologics, Moderna, Inc., Syngene International, Meridian Life Sciences, Eurogentec, IDT Biologika, Serum Institute of India, GlaxoSmithKline (GSK), Soligenix Inc., Curia, Cobra Biologics, BioReliance, Recipharm, Jubilant HollisterStier, and others
• Porter's Five Forces Analysis, Product Profiles, Case Studies, KOL's Views, Analyst's View
Interested in knowing how the Vaccine Contract Manufacturing market will grow by 2032? Click to get a snapshot of the Vaccine Contract Manufacturing Market Analysis
https://www.delveinsight.com/sample-request/vaccine-contract-manufacturing-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Contact Us
Gaurav Bora
info@delveinsight.com
+14699457679
www.delveinsight.com
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end-to-end comprehensive solutions to improve their performance.
Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Vaccine Contract Manufacturing Market Size to grow at a CAGR of 6.9% to reach USD 3,905.96 million by 2032, Evaluates DelveInsight here
News-ID: 4278827 • Views: …
More Releases from DelveInsight Business Research
Global Nucleic Acid Amplification Testing Market Size to grow at a CAGR of 8.13% …
According to DelveInsight's analysis, The increasing demand for nucleic acid amplification testing (NAAT) is being fueled by several major factors, most notably the growing prevalence of infectious and genetic disorders. This demand is further strengthened by the rising number of cancer cases and the expanding R&D efforts undertaken by key industry participants. Together, these elements are expected to support a strong growth outlook for the NAAT market during the forecast…
Global Patient Engagement Solutions Market Size to grow at a CAGR of 12.15% to r …
According to DelveInsight's analysis, Several major factors are fueling the demand for patient engagement solutions, with the growing burden of chronic conditions such as diabetes and cardiovascular diseases-which require continuous monitoring and active patient involvement-being a primary driver. Additionally, the healthcare industry's transition toward patient-centered care, along with technological innovations and the introduction of new products, is further propelling market growth.
DelveInsight's "Patient Engagement Solutions Market Insights, Competitive Landscape and Market…
Global Urinalysis Market Size to grow at a CAGR of 9.10% to reach USD 9,021.90 m …
According to DelveInsight's analysis, the growing incidence of urinary conditions including UTIs, chronic kidney diseases, and hospital-acquired infection is significantly boosting the need for urinalysis, as early detection plays a vital role in effective treatment. Rising health awareness and various public health initiatives are also encouraging routine screenings, prompting individuals to undergo timely diagnostic tests. Educational programs by healthcare organizations further highlight the importance of urinalysis in preventive healthcare. In…
Global Advanced Melanoma Pipeline Accelerates With 60+ Emerging Therapies, Revea …
DelveInsight's "Advanced Melanoma Pipeline Insight 2025" report delivers an in-depth analysis of more than 55 companies and over 60 investigational therapies currently advancing through the Advanced Melanoma research landscape. It offers detailed profiles of both clinical- and preclinical-stage candidates and provides a thorough evaluation of therapies based on product type, development stage, route of administration, and molecule class. The report also outlines inactive or discontinued programs within this domain.
Explore the…
More Releases for Vaccine
Adult Vaccines Market By Type (Preventive Vaccine, Therapeutic Vaccine)
Global Adult Vaccines Market 2022 Research Report initially provides a basic overview of the industry that covers definition, applications and manufacturing technology, post which the report explores into the international players in the market.
Download Sample PDF at https://www.theinsightpartners.com/sample/TIPRE00007244/?utm_source=OpenPR&utm_medium=10379
Key Players Analysis:
AstraZeneca
Bharat Biotech
Dynavax Technologies Corporation
GlaxoSmithKline
Johnson & Johnson
Merck and Co
Novartis
Pfizer
Sanofi Pasteur
Serum Institute of India
The report covers key developments in the Adult Vaccines market as organic and inorganic growth strategies. Various companies are focusing…
Flu Vaccine (Influenza Vaccine) Market: A look into the future of the “Univers …
Latest update on Flu Vaccine (Influenza Vaccine) Market Analysis Report published with an SMI, the industry growth analysis, and Projection by 2021-2028. This report is highly predictive as it holds the overall market analysis of the topmost companies in the Flu Vaccine (Influenza Vaccine) industry. With the classified Flu Vaccine (Influenza Vaccine) market research based on various growing regions, this report provides leading players' portfolios along with sales, growth, market…
Vaccine Market
Rise in the prevalence of infectious diseases, increase in immunization programs across the globe, and surge in R&D activities to develop new vaccine drive the growth of the global vaccine market.
Global Vaccines Market was pegged at $32.46 billion in 2019, and is anticipated to hit $54.15 billion by 2027, registering a CAGR of 6.6% from 2020 to 2027. The report provides an in-depth analysis of the top investment pockets, top…
US Flu Vaccine [Influenza Vaccine] Market Research Report 2020
DPI Research offers a latest published report on “Influenza Vaccines in the United States – Market Size, Trends, Opportunities and Growth Potential” delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key US flu vaccines market players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze…
Measles Vaccine
Measles Vaccine Market describes its growth, size, share, Forecast and trends to 2025
Measles Vaccine Market Production and Demand Analysis 2019 to 2025
Measles Vaccine Market 2019 Manufacturing Analysis and Development Forecast 2025
Measles Vaccine Market 2019: Recent Study Including Growth Factors, Regional Drivers, Forecast 2025
Measles Vaccine Market to Insight By 2025: Top Key Vendors
The global Measles Vaccine market is valued at million US$ in 2018 and will reach million US$ by the…
Monovalent vaccine segment to accumulate maximum Paediatric Vaccine Market share
According to a new report published by Future Market Insights titled “Paediatric Vaccine Market: Global Industry Analysis & Opportunity Assessment, 2016 – 2026”, in terms of revenue, the global paediatric vaccine market is expected to increase at 12.2% CAGR during the forecast period 2016-2026. The global paediatric vaccine market is expected to reach US$ 27.97 Bn in 2016.
Paediatric vaccine market is a billion dollar market accounting for a substantial proportion…
